| Title | Endocrine, Metabolic and Immune Disorders - Drug Targets |
| Abbreviation | Endocr. Metab. Immune Disord. - Drug Targets |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3) |
| h-index | 55 |
| Overall Rank/Ranking | 10190 |
| SCImago Journal Rank (SJR) | 0.49 |
| Impact Score | 2.31 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 18715303 |
Endocrine, Metabolic and Immune Disorders - Drug Targets is a journal covering the technologies/fields/categories related to Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of Endocrine, Metabolic and Immune Disorders - Drug Targets is 10190. According to SCImago Journal Rank (SJR), this journal is ranked 0.49. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 55. The best quartile for this journal is Q3.
The ISSN of Endocrine, Metabolic and Immune Disorders - Drug Targets journal is 18715303. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Endocrine, Metabolic and Immune Disorders - Drug Targets is cited by a total of 997 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Endocrine, Metabolic and Immune Disorders - Drug Targets is 2.31, which is computed in 2022 as per its definition. Endocrine, Metabolic and Immune Disorders - Drug Targets IS is decreased by a factor of 0.37 and approximate percentage change is -13.81% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Endocrine, Metabolic and Immune Disorders - Drug Targets is 2.31. If the same downward trend persists, impact score may fall in 2022 as well.
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 2.31 |
| 2020 | 2.68 |
| 2019 | 1.97 |
| 2018 | 1.27 |
| 2017 | 2.02 |
| 2016 | 2.23 |
| 2015 | 2.04 |
| 2014 | 1.77 |
Endocrine, Metabolic and Immune Disorders - Drug Targets has an h-index of 55. It means 55 articles of this journal have more than 55 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Endocrine, Metabolic and Immune Disorders - Drug Targets is 18715303. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Endocrine, Metabolic and Immune Disorders - Drug Targets is 10190. According to SCImago Journal Rank (SJR), this journal is ranked 0.49. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Endocrine, Metabolic and Immune Disorders - Drug Targets is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Endocrine, Metabolic and Immune Disorders - Drug Targets is Endocr. Metab. Immune Disord. - Drug Targets. This abbreviation ('Endocr. Metab. Immune Disord. - Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Babol University of Medical Sciences | journal | 21761 | Babol University of Medical Sciences | 16 | 0.35 |
| Security Dialogue | journal | 3155 | SAGE Publications Ltd | 75 | 3.38 |
| Journal of Mechanics of Materials and Structures | journal | 13051 | Mathematical Sciences Publishers | 44 | 1.74 |
| Southwestern Historical Quarterly | journal | 26398 | University of Texas Press | 7 | 0.04 |
| EuroIntervention | journal | 1720 | EuroPCR | 82 | 3.26 |
| Sound and Vibration | trade journal | 20331 | Tech Science Press | 34 | 0.50 |
| Journal of Laser Micro Nanoengineering | journal | 15043 | Japan Laser Processing | 28 | 1.30 |
| Acta Obstetricia et Gynecologica Scandinavica | journal | 2923 | Wiley-Blackwell | 106 | 3.79 |
| Turkish Journal of Mathematics | journal | 10729 | TUBITAK | 29 | 0.95 |
| Chemometrics and Intelligent Laboratory Systems | journal | 6445 | Elsevier | 132 | 4.22 |
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 2.31 |
| 2020 | 2.68 |
| 2019 | 1.97 |
| 2018 | 1.27 |
| 2017 | 2.02 |
| 2016 | 2.23 |
| 2015 | 2.04 |
| 2014 | 1.77 |
2.31
55
10190
0.49
